Odimma Therapeutics logo

Odimma Therapeutics jobs and careers

France

About Odimma Therapeutics

Odimma is a French biotech company with a unique approach in active personalized cancer immunotherapy. Immunotherapy has revolutionized the treatment of many advanced cancers. Despite this amazing achievement, significant clinical benefits are still limited to 10 to 30% of patients. Odimma believes in the future of precision medicine, and leverages recent advances in the field of immuno-oncology to amplify the efficacy of current therapies, improving lives and making each patient unique. By harnessing the ability of the patient’s own immune system to specifically recognize non-self-targets displayed by the tumor, also called neoantigens, Odimma has designed a next-generation personalized immunization platform that brings a sustainable therapeutic solution to fight the most hard-to-treat cancers. Carried by a team of experts and a supportive environment, we are now preparing our upcoming entry in the clinic

Founded in 2017 by Jessica Matta.

Founded
2017
Employees
1 to 10
Total funding
$2M
Headquarters
France

Leadership

The top of Odimma Therapeutics's org chart, with how many people report into each leader.

JLPhoto of Jean-Marc LIMACHER

Jean-Marc LIMACHER

Chairman, Chief Medical Officer

Jobs at Odimma Therapeutics

No open positions right now. Explore more companies on TheJobsMap.